HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine.

AbstractBACKGROUND:
Hydrodynamic injection of naked plasmid DNA (pDNA) via the tail vein is a safe and effective method of gene transfer to the liver. However, successful gene transfer has yet to be shown for hepatocellular carcinoma (HCC); therefore, we investigated the feasibility and efficacy of hydrodynamic injection via the tail vein and hepatic artery in a diethylnitrosamine (DEN)-induced HCC model in rats.
METHODS:
HCC was induced in Sprague-Dawley rats by 100 ppm DEN in drinking water. pCMV-SPORT-beta-galactosidase (beta-gal, 400 microg) was injected (i) via the tail vein in a volume of 0.1 ml/g in 30 s or (ii) via the hepatic artery in a volume of 5 or 10 ml at 1 ml/s, either with or without temporary occlusion of the inferior vena cava (IVC) and portal vein (PV). The liver was harvested 24 h after administration, and beta-gal expression was evaluated with X-gal staining and measurement of enzymatic activity in tissue homogenates.
RESULTS:
Hydrodynamic injection via the tail vein achieved transgene expression only in non-cancerous tissue (tumor: 0.16 +/- 0.04%, non-tumor: 5.07 +/- 1.66%). Hydrodynamic injection via the hepatic artery was tolerated, but failed to produce efficient transgene expression in tumor and non-tumor cells. On the other hand, concomitant use of temporary IVC/PV occlusion with hydrodynamic injection via the hepatic artery dramatically increased transgene expression in cancer cells, but tumor-selective gene transfer was not achieved with this procedure (tumor: 7.38 +/- 3.66%, non-tumor: 7.77 +/- 1.06%).
CONCLUSIONS:
High-volume hydrodynamic injection of a pDNA solution via the hepatic artery with IVC/PV occlusion achieved a high level of gene expression in a HCC rat model. This gene transfer technique may have potential in clinical gene therapy for HCC.
AuthorsMasaharu Tada, Etsuro Hatano, Kojiro Taura, Takashi Nitta, Naoki Koizumi, Iwao Ikai, Yasuyuki Shimahara
JournalThe journal of gene medicine (J Gene Med) Vol. 8 Issue 8 Pg. 1018-26 (Aug 2006) ISSN: 1099-498X [Print] England
PMID16779866 (Publication Type: Comparative Study, Journal Article)
Copyright2006 John Wiley & Sons, Ltd.
Chemical References
  • Alkylating Agents
  • Carcinogens
  • Diethylnitrosamine
  • DNA
  • beta-Galactosidase
  • Indocyanine Green
Topics
  • Alkylating Agents
  • Animals
  • Carcinogens
  • Carcinoma, Hepatocellular (metabolism, pathology, therapy)
  • Cytomegalovirus (genetics)
  • DNA (administration & dosage, genetics)
  • Diethylnitrosamine
  • Disease Models, Animal
  • Gene Expression
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Genetic Vectors (chemistry, genetics)
  • Hepatic Artery (metabolism)
  • Indocyanine Green (metabolism)
  • Injections, Intravenous
  • Liver Neoplasms (metabolism, pathology, therapy)
  • Male
  • Plasmids (administration & dosage, genetics)
  • Rats
  • Rats, Sprague-Dawley
  • Transgenes
  • beta-Galactosidase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: